Tecentriq Hybreza
(teh-SEN-trik hy-BREE-zuh)
A combination of two drugs used alone or with other drugs to treat adults with certain types of alveolar soft part sarcoma (a type of soft tissue tumor), hepatocellular carcinoma (a type of liver cancer), melanoma, non-small cell lung cancer, and small cell lung cancer. Atezolizumab binds to a protein called PD-L1, which is found on some normal cells and some types of cancer cells. Atezolizumab may block PD-L1 and help the immune system kill cancer cells. Hyaluronidase allows atezolizumab to be given by injection under the skin. Tecentriq Hybreza can be given in less time than atezolizumab alone, which is given as an infusion. Also called atezolizumab and hyaluronidase.